WO2008038721A1 - Lentille oculaire - Google Patents

Lentille oculaire Download PDF

Info

Publication number
WO2008038721A1
WO2008038721A1 PCT/JP2007/068831 JP2007068831W WO2008038721A1 WO 2008038721 A1 WO2008038721 A1 WO 2008038721A1 JP 2007068831 W JP2007068831 W JP 2007068831W WO 2008038721 A1 WO2008038721 A1 WO 2008038721A1
Authority
WO
WIPO (PCT)
Prior art keywords
group
ophthalmic lens
silicone
monomer
lens according
Prior art date
Application number
PCT/JP2007/068831
Other languages
English (en)
Japanese (ja)
Inventor
Kazuhiko Fujisawa
Tsutomu Goshima
Masataka Nakamura
Original Assignee
Toray Industries, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Toray Industries, Inc. filed Critical Toray Industries, Inc.
Publication of WO2008038721A1 publication Critical patent/WO2008038721A1/fr

Links

Classifications

    • G—PHYSICS
    • G02—OPTICS
    • G02B—OPTICAL ELEMENTS, SYSTEMS OR APPARATUS
    • G02B1/00—Optical elements characterised by the material of which they are made; Optical coatings for optical elements
    • G02B1/04—Optical elements characterised by the material of which they are made; Optical coatings for optical elements made of organic materials, e.g. plastics
    • G02B1/041—Lenses
    • G02B1/043—Contact lenses

Definitions

  • the present invention relates to an ophthalmic lens, and the ophthalmic lens is particularly preferably used for a contact lens, an intraocular lens, an artificial cornea, and the like.
  • the present invention has the following configuration. That is,
  • An ophthalmic lens comprising: a polymer compound (A) having a monomer unit having an ammoium group in the molecule, dispersed in a gel or gel (B).
  • Polar basic force S hydroxyl group, amide group, carboxyl group, amino group, carbonate group, carbamate group, sulfonamide group, sulfonic acid group, phosphonic acid group of the polar silicone component
  • the ophthalmic lens as described in (4) above which is a group selected from the group consisting of methoxyethyl group, methoxyethoxyethyl group, hydroxyethyl group, and hydroxyethoxyethyl group.
  • At least one of the silicone components is represented by the following general formula (a)
  • the ophthalmic lens according to any one of (3) to (5) above which has a structure obtained from a silicone monomer represented by
  • M represents a polymerizable group capable of radical polymerization.
  • L represents an optionally substituted divalent organic group having 1 to 20 carbon atoms.
  • A represents a siloxanyl group.
  • At least one of the silicone monomers is represented by the following formulas (d), (e) and (g) [0007] [Chemical Formula 2]
  • the ophthalmic lens as described in (6) above which is a monomer selected from the group consisting of force and the like.
  • R 1 represents an optionally substituted alkyl group having 1 to 30 carbon atoms.
  • R 2 to R 7 are substituted with 1 to 20 carbon atoms! /, May! /, Alkyl groups or carbon atoms.
  • X— represents any anion.
  • the ophthalmic lens of the present invention is obtained by dispersing a polymer compound having an ammonium group in a molecule in a hyde mouth gel which is a hydrophilic polymer having a network structure.
  • a polymer compound having an ammonium group in a molecule in a hyde mouth gel which is a hydrophilic polymer having a network structure.
  • that the polymer compound is dispersed in the hyde mouth gel does not include the case where the polymer compound is simply attached to the hyde mouth gel surface, and the ophthalmic lens surface is cleaned by ultrasonic cleaning using water. After washing, when the polymer compound contained in the ophthalmic lens is extracted with an organic solvent, the polymer compound having an ammonium group in the molecule is extracted.
  • a polymer compound having an ammonium group in the molecule is extracted by the extraction operation, it is determined that the polymer compound is dispersed in the gel. Specifically, extraction is performed using methanol, ethanol, 2-propanol, toluene, hexane, acetone, methyl ethyl ketone, ethyl acetate, butyl acetate, tetrahydrofuran, dimethyl sulfoxide as an organic solvent, and at least one of these is used.
  • a polymer compound having an ammonium group in the molecule is extracted by 0.1% or more of the dry weight of the hide-mouthed gel, it is determined that the polymer compound is dispersed.
  • the hydrophilic monomer used in the hide-mouthed gel (B) of the ophthalmic lens of the present invention is not particularly limited as long as it can be polymerized.
  • (Meth) Atalyloyl group, styryl group, allyl group, bulle Monomers having other groups and other polymerizable carbon-carbon unsaturated bonds can be used.
  • the hydrogel is preferably a silicone hydride gel further containing a silicone component. If the content of the silicone component in the silicone hydride gel is small, the oxygen permeability necessary for continuous use of the ophthalmic lens cannot be obtained, and if it is large, the compatibility with the hydrophilic component is difficult to obtain. Therefore, when the total weight of various monomers is 100 parts by weight, the content of the silicone monomer is preferably 20 to 80 parts by weight, more preferably 30 to 80 parts by weight, and most preferably 50 to 80 parts by weight. ! /
  • the hyde mouth gel (B) of the ophthalmic lens of the present invention is a silicone hyde mouth gel, a polymer compound having a hydrophobic silicone component and a monomer unit having a hydrophilic ammonium group (In order to obtain sufficient compatibility with (A), it is preferable that 30% or more of the number of key atoms in the silicone component is a key atom in the polar silicone component, and more than 40% is more. 50% or more is most preferable.
  • the polar silicone component represents a structure obtained by polymerizing a polar silicone monomer having a polar group in the molecule.
  • polar groups include hydroxyl groups, amide groups, carboxynole groups, amino groups, carbonate groups, carbamate groups, sulfonamide groups, sulfonic acid groups, phosphonic acid groups, methoxyethyl groups, methoxyethoxyethyl groups, hydroxyethyl groups. Group, hydroxyethoxyethyl group and the like.
  • the ophthalmic lens of the present invention is a silicone nodule gel
  • a hydroxyl group such as 2-hydroxyethyl (meth) acrylate is particularly used as a hydrophilic monomer. It is preferred to copolymerize (meth) acrylate monomers that have! use If the amount used is too small, the effect of improving transparency cannot be obtained. If too much is used, the physical properties of the polymer will be affected, so 0.;! ⁇ 25 parts by weight is preferred 0.5 to 20 parts by weight Parts are more preferred, 1.0-- 15 parts by weight is most preferred.
  • the number of hydroxyl groups in the ophthalmic lens is OH and the number of ammonium nitrogen is N, if the N / OH ratio is too small, sufficient antibacterial properties cannot be obtained, and if it is too large, the ophthalmic lens has sufficient transparency. In this case, 0.001 to 0.5 is preferable, 0.005 to 0.4 is more preferable, 0.0;! To 0.3 is also preferable.
  • the method for measuring the N / OH ratio is selected according to the type and amount of each component in the hide-mouth gel and the antibacterial polymer, and examples thereof include nuclear magnetic resonance (NMR) and infrared spectroscopy.
  • IR IR
  • ATR total reflection infrared absorption measurement
  • UV ultraviolet spectroscopy
  • Examples of the polymerization method of the silicone hydride gel used in the ophthalmic lens of the present invention include a method obtained by polymerizing a mixture of various monomers such as a silicone monomer, a hydrophilic monomer, and a crosslinking monomer, a silicone monomer, a hydrophilic monomer, and the like. Examples include a method in which various monomers are homopolymerized or copolymerized, and then a macromonomer having a polymerizable group introduced is polymerized.
  • the silicone monomer obtained by polymerizing the silicone hydride gel of the present invention from a monomer functions as a cross-linking agent when it has two or more polymerizable groups, and the resulting elastic modulus of the silicone nodulogel Is too high, the following general formula (a)
  • a silicone monomer having a structure having one polymerizable group in the molecule is preferred! /.
  • ⁇ represents a polymerizable group capable of radical polymerization.
  • the polymerizable group capable of radical polymerization include vinylene group, vinylol group, vinyloxy group, aryloxy group, bull force rubamate group, aryl carbamate group, bull carbonate group, aryl carbonate group, metatalolyl group, allyloyl group, styryl group. Groups and the like.
  • the attalyloyl group and the methacryloyl group are preferable from the viewpoint of the elastic modulus of the obtained polymer.
  • L represents an optionally substituted divalent organic group having carbon number;
  • an alkylene group is more preferable.
  • Divalent hydrocarbon groups such as tilethylene, n-propylene, n-butylene, 2-methylpropylene, 2,2-dimethylpropylene, n-pentylene, 2-hydroxypropylene, 2-hydroxybutylene, 3
  • a divalent organic group having a hydroxyl group such as a hydroxybutylene group, a divalent organic group having an ether bond as represented by the following formulas (L1 ;!) to (L3), and the following formula ( Examples thereof include divalent organic groups having both an ether bond and a hydroxyl group represented by formulas such as L 4) and (L 5).
  • M is most preferably 1-5.
  • Sx represents a siloxanyl group.
  • the siloxanyl group represents a group having at least one Si—O—Si bond in the structure.
  • the silicone monomer represented by the general formula (a) is preferably the one represented by the following general formula (a ').
  • n represents an integer of 0 to 200.
  • a, b and c each independently represents an integer of 0 to 20.
  • n + a + b + c represents the number of siloxane bonds in the silicone compound. If the number of n + a + b + c is too small, the oxygen permeability required for ophthalmic lenses and contact lenses will be sufficient. If the amount is too large, the compatibility with various hydrophilic monomers often used as a copolymerization component is reduced, and a transparent lens cannot be obtained. More preferably, 2 to 50 is most preferable.
  • Ai A 11 represents an optionally substituted alkyl group having 1 to 20 carbon atoms or an optionally substituted aryl group having 6 to 20 carbon atoms. Substituent represented by the above structure Among them, the compound having such a substituent is industrially available at a relatively low cost.
  • silicone monomers represented by the general formula (a) those that are preferable in terms of compatibility with hydrophilic monomers and ammonium salt monomers, oxygen permeability of polymers obtained by polymerization, mechanical properties, and the like are preferable.
  • Q represents an alkyl group having 1 to 8 carbon atoms.
  • P represents an integer of 1 to 20.
  • a transparent silicone polymer can be easily obtained even when mixed with an internal wetting agent such as polybulurpyrrolidone, a silicone monomer having a hydroxyl group in the molecule as represented by formula (e) or formula (i). Is most preferred.
  • the macromonomer is a monomer having a molecular weight of 800 or more and having one or more polymerizable groups.
  • the silicone nodule gel used in the ophthalmic lens of the present invention is obtained from a macromonomer
  • the above-mentioned various silicone monomers are homopolymerized and then introduced with a polymerizable group to co-polymerize with various hydrophilic monomers and the like.
  • Polymerization method, various silicone monomers, various hydrophilic monomers And the like, and then polymerizing by introducing a polymerizable group is preferable because compatibility between the silicone component and the hydrophilic component is easily increased.
  • the molecular weight of the silicone macromonomer is too low, one of the advantages of using the macromonomer is that the effect of inhibiting polymerization shrinkage is not sufficient, and if the molecular weight is too high, the viscosity of the macromonomer becomes too high and handling becomes difficult. From the viewpoint of lowering the solubility in the polymerization solvent, 1000 to 1,000,000 S is preferable, 3000 to 500,000 S is more preferable, and 500 00 to 100,000 is most preferable.
  • the ammonium salt monomer constituting the polymer compound used in the ophthalmic lens of the present invention may be any monomer having a polymerizable group and an ammonium cation in the molecule.
  • the polymerizable group is not particularly limited as long as it can be radically polymerized.
  • Ataryloyl group (meth) acrylamido group, styryl group, allyl group, bur group, and other radically polymerizable carbon-carbon unsaturated bonds
  • ammonium cation may be independently substituted with three substituent groups other than one leading to a polymerizable group on the nitrogen atom, or may be substituted with an alkyl group having 1 to 20 carbon atoms or substituted! / Or, it is an aryl group having 6 to 20 carbon atoms, and these substituents may form a ring with each other. Examples of more specific structures are the following general formulas (f), (h), (i)
  • R 8 to R 1 () are each independently an optionally substituted alkyl group having 1 to 20 carbon atoms or an optionally substituted carbon number 6 Represents an aryl group of ⁇ 20, R 11 represents hydrogen or a methyl group, Z represents O or NH, X— represents an arbitrary anion, and the like.
  • the burium imidazolium salt represented by the general formula (f) is most preferable in terms of heat stability and antibacterial properties.
  • R 1 represents an optionally substituted alkyl group having 1 to 30 carbon atoms. If the number of carbon atoms is small, the hydrophilicity of the ammonium cation moiety makes it compatible with the silicone monomer. When the number of carbon atoms is too low, the compatibility with hydrophilic monomers decreases, so 4 to 20 carbon atoms are more preferred! /.
  • R 2 to R 7 are optionally substituted alkyl groups having 1 to 20 carbon atoms or substituted with 6 to 20 carbon atoms! /, May! /, Aryl Represents a group.
  • R 2 may form a ring! / ⁇ .
  • X— represents an arbitrary anion.
  • examples thereof include halide ions such as fluoride ions, chloride ions, bromide ions, iodide ions, hydroxide ions, sulfate ions, nitrate ions, boron tetrafluoride ions, and the like. Of these, halide ions are most preferred from the viewpoint of ease of synthesis.
  • the polymer compound of the present invention may be a homopolymer of ammonium salt monomers or a copolymer with other monomers.
  • the total weight of the various monomers in the copolymer is 100 parts by weight, the content of the ammonium salt monomer is too small to obtain sufficient antibacterial properties. More than 30 parts by weight is most preferred!
  • Examples of the monomer in the case where the polymer compound used in the ophthalmic lens of the present invention is copolymerized with a monomer other than the ammonium salt monomer are not particularly limited as long as copolymerization is possible (meta-metabolism). ) Monomers having an allyloyl group, a styryl group, a allyl group, a bur group, and other polymerizable carbon'carbon unsaturated bonds can be used.
  • Examples include amide monomers such as N-Buylpyrrolidone, N, N-Dimethylacrylamide, N-Buylformamide, N-Bulucacetamide, 2-Hydroxyethyl methacrylate, and 2 (2-Hydroxyl).
  • Monomers having a hydroxyl group such as ethoxy) ethyl methacrylate, silicone monomers such as 3-tris (trimethylsiloxy) silylpropyl methacrylate, polydimethylsiloxane having a (meth) acryl group at one or both ends And so on.
  • an amide monomer and a monomer having a hydroxyl group are more preferable because they are easily compatible with an ammonium salt monomer, and N-vinylpyrrolidone is most preferable.
  • the molecular weight of the polymer compound used in the ophthalmic lens of the present invention is too small, the polymer compound is likely to elute the substrate, and if it is too large, the polymer compound monomer mixture or a liquid containing it is contained. Since the solubility with respect to the immersion solution is lowered, 1000 to 1 million, preferably S, more preferably 5,000 to 500,000, most preferably 10,000 to 300,000.
  • two or more copolymerizable carbons in one molecule are obtained in the sense that good mechanical properties are obtained and good resistance to a disinfecting solution and a cleaning solution is obtained. It is preferable to use a monomer having a carbon unsaturated bond as a copolymerization component.
  • the copolymerization ratio of two or more copolymerizable carbon-carbon unsaturated bonds in one molecule is preferably 0.;! To 20% by weight, preferably 0.3 to 15% by weight, more preferably 0 5 to 10% by weight is more preferable.
  • the ophthalmic lens of the present invention may contain an ultraviolet absorber, a pigment, a colorant, and the like! It may also contain UV-absorbers, dyes, and colorants having a polymerizable group in a copolymerized form! / ⁇
  • a thermal polymerization initiator typified by a peroxide or a azo compound or a photopolymerization initiator in order to facilitate polymerization.
  • thermal polymerization select one having the optimum decomposition characteristics for the desired reaction temperature.
  • azo initiators and peroxide initiators having a 10-hour half-life temperature of 40 ° C to 120 ° C are suitable.
  • the photopolymerization initiator include carbonyl compounds, peroxides, azo compounds, sulfur compounds, halogen compounds, and metal salts. These polymerization initiators are used alone or in combination, and are used in an amount of up to about 1% by weight.
  • a polymerization solvent can be used.
  • the solvent various organic and inorganic solvents are applicable and there is no particular limitation.
  • aromatic hydrocarbon solvents such as hexane, heptane, octane, decane, petroleum ether, kerosene, rig in, para
  • Various aliphatic hydrocarbon solvents such as fins, various ketone solvents such as acetone, methyl ethyl ketone and methyl isobutyl ketone, various ester systems such as ethyl acetate, butyl acetate, methyl be
  • the polymerization method and molding method for the ophthalmic lens of the present invention ordinary methods can be used. For example, a method of once forming a round bar or a plate and processing it into a desired shape by cutting or the like, a mold polymerization method, a spin cast method, or the like.
  • the ophthalmic lens of the present invention is obtained by the mold polymerization method will be described below.
  • the monomer composition is filled in the space between two molds having a certain shape. Then, photopolymerization or thermal polymerization is performed to shape the mold.
  • the mold is made of resin, glass, ceramics, metal, etc., but in the case of photopolymerization, an optically transparent material is used, and usually resin or glass is used.
  • a polymer is produced, in many cases, a void is formed by two opposing molds, and the force S that fills the void with the monomer composition S, and depending on the shape of the mold and the properties of the monomer, A gasket having the purpose of giving a constant thickness and preventing leakage of the filled monomer composition may be used in combination.
  • the mold in which the voids are filled with the monomer composition is heated by being put in an oven or a liquid bath with the power to be irradiated with an actinic ray such as ultraviolet rays to polymerize the monomer.
  • an actinic ray such as ultraviolet rays to polymerize the monomer.
  • an actinic ray such as ultraviolet rays to polymerize the monomer.
  • both are used in combination, such as heat polymerization after photopolymerization or conversely photopolymerization after heat polymerization.
  • photopolymerization it is common to irradiate light containing a large amount of ultraviolet light using a mercury lamp or insect trap as a light source for a short time (usually 1 hour or less).
  • the high molecular compound is dispersed in the network structure of the base hydrated gel.
  • a method of dispersing a polymer compound in a base material a method of polymerizing a hide-mouth gel in a state where a polymer compound is mixed in a raw monomer or raw material macromonomer mixture of a hide-mouth gel, Examples include a method of impregnating by impregnating in a solution of a molecular compound.
  • various organic and inorganic solvents can be applied to the polymer compound solution, and there is no particular limitation.
  • examples include water, methanol, ethanol, propanol, 2-propanol monoole, butanol, tert-butanol, tert-amyl alcohol, various alcohol solvents such as 3,7-dimethyl-3-octanol, benzene, toluene, xylene, etc.
  • concentration of the aqueous solution of the polymer compound is too low, sufficient antibacterial properties cannot be obtained, and if it is too high, it may be necessary to wash the excess polymer compound. 30% preferred 0.5 to 20% is more preferred;! To 10% is most preferred.
  • the ophthalmic lens of the present invention can be modified by various methods. It is preferable to perform a modification treatment that improves the wettability of the surface.
  • Specific reforming methods include electromagnetic wave (including light) irradiation, plasma irradiation, chemical vapor deposition treatment such as vapor deposition and sputtering, heating, base treatment, acid treatment, and other suitable surfaces. Mention may be made of the use of treatment agents and combinations thereof. Among these reforming means, simple and preferred are base and acid treatments.
  • Examples of the base treatment or acid treatment include a method of contacting an ophthalmic lens with a basic or acidic solution, a method of contacting an ophthalmic lens with a basic or acidic gas, and the like. More specific methods include, for example, a method in which an ophthalmic lens is immersed in a basic or acidic solution, a method in which a basic or acidic solution or basic or acidic gas is sprayed on an ophthalmic lens, or an ophthalmic lens. For example, a method of applying a basic or acidic solution with a spatula, a brush or the like, and applying a basic or acidic solution to an ophthalmic lens by a spin coating method or a dip coating method can be cited. The most simple method for obtaining a great modification effect is a method of immersing an ophthalmic lens in a basic or acidic solution.
  • the temperature at which the ophthalmic lens is immersed in a basic or acidic solution is not particularly limited, but is usually within a temperature range of about 50 ° C to 300 ° C. Considering workability, a temperature range of 10 ° C to 150 ° C is more preferable-5 ° C to 60 ° C is most preferable.
  • the time when the ophthalmic lens is immersed in a basic or acidic solution! / The force that changes the optimum time depending on the temperature Generally 0.;! ⁇ 100 hours are preferred 0.3 ⁇ 24 hours Is more preferable within 0.5; most preferably within 12 hours. If the contact time is too short, a sufficient treatment effect cannot be obtained, and if the contact time is too long, if workability and productivity are deteriorated, not only the power but also the oxygen permeability and mechanical properties are reduced. There may be adverse effects.
  • Examples of the base include alkali metal hydroxides, alkaline earth metal hydroxides, various carbonates, various borates, various phosphates, ammonia, various ammonium salts, various amines and polyethyleneimine, High molecular weight bases such as polybulamine can be used. Of these, alkali metal hydroxides are most preferred because of their low cost and great treatment effect.
  • Examples of acids include various inorganic acids such as sulfuric acid, phosphoric acid, hydrochloric acid, and nitric acid, various organic acids such as acetic acid, formic acid, benzoic acid, and phenol, and various high molecular weight acids such as polyacrylic acid and polystyrene sulfonic acid. It can be used. Among these, polyacrylic acid is most preferable from the viewpoint of acidity and solubility among those preferred to high molecular weight acids because they have a large treatment effect and little adverse effect on other physical properties. .
  • the solvent of the basic or acidic solution various inorganic and organic solvents can be used.
  • aromatic hydrocarbons such as hexane, heptane, octane, decane, petroleum ether, kerosene, lignin, paraffin and other aliphatic hydrocarbons, acetone, methyl ethyl ketone, methyl isobutyl ketone and other ketones, acetic acid
  • esters such as ethyl acetate, butylacetate, methyl benzoate, dioctyl phthalate, etc., jetyl ether, tetrahydrofuran, di
  • aprotic polar solvents such as dimethylformamide, dimethylacetamide, N-methyl-2-pyrrolidone, dimethylimidazolidinone, hexamethylphosphoric triamide, dimethyl sulfoxide, methylene chloride, chloroform, dichloroethane, Halogen solvents such as trichloroethane and trichlorethylene, and fluorocarbon solvents.
  • water is most preferable from the viewpoints of economy, ease of handling, chemical stability, and the like.
  • the solvent a mixture of two or more substances can be used.
  • the basic or acidic solution used in the present invention may contain a basic or acidic substance and components other than the solvent.
  • the ophthalmic lens is treated with a force S to remove a basic or acidic substance by washing after the base treatment or the acid treatment.
  • the cleaning solvent various inorganic and organic solvents can be used.
  • the cleaning solvent a mixture of two or more kinds of solvents may be used.
  • the cleaning solvent may contain components other than the solvent, such as inorganic salts, surfactants, and cleaning agents.
  • the modification treatment may be performed on the entire ophthalmic lens, or may be performed only on a part of the ophthalmic lens, for example, only on the surface.
  • only the surface is modified, only the water wettability of the surface can be improved without greatly changing the properties of the entire ophthalmic lens, and the surface water of the ophthalmic lens using the polymer of the present invention can be improved.
  • internal wettability is achieved by polymerizing the monomer mixture at the time of polymerization with a hydrophilic polymer added, and retaining the hydrophilic polymer in the ophthalmic lens to improve the surface water wettability.
  • hydrophilic polymers used as internal wetting agents include polybulu cyclic amides such as polybulurpyrrolidone, polybulu cyclic amines such as polybutimidazole, polyacrylamides such as poly N, N-dimethylacrylamide, and polybular alcohol. And polyalcohols such as polyacrylic acid, polycarboxylic acids such as polyacrylic acid, polyethylene glycols, mixtures thereof, and copolymers. Of these, the eyes Most preferred from the viewpoint of improving the wettability of the lens surface is polybulurpyrrolidone.
  • oxygen permeability coefficient 70 X 10— U to 500 X 10— u (cm 2 / sec) mLO / (mL -h
  • the antibacterial properties of the ophthalmic lens of the present invention are as follows.
  • the average of the number of bacteria after cultivation was 3 times the initial number of bacteria before culture. If it is within 4 times the average number of times, it is considered that there is no growth and is judged to have antimicrobial effect. More preferably, it is 10% or less of the average number of control bacteria, and most preferably 1% or less of the number of control bacteria.
  • the polymer of the present invention is particularly suitable as an ophthalmic lens such as a contact lens, an intraocular lens, and an artificial cornea.
  • the obtained film-like sample was peeled from the glass plate by applying ultrasonic waves in water for 20 minutes, immersed in a 60% IPA aqueous solution at 60 ° C, and further immersed in an 80% IPA aqueous solution at 60 ° C. Impregnation such as residual monomer was extracted by immersion for 2 hours, and hydrated by immersing in 50% IPA aqueous solution, 25% aqueous solution, and water with gradually decreasing IPA concentration for approximately 30 minutes. It was immersed in a borate buffer solution ( ⁇ 7 ⁇ ;!-7.3) in a 200 mL glass bottle, and the glass bottle was placed in an autoclave and boiled at 121 ° C. for 30 minutes. After allowing to cool, the film-like sample was taken out from the glass bottle and immersed in a borate buffer ( ⁇ 7 ⁇ !-7.3). The obtained film-like sample was cut into 3 cm squares to obtain antibacterial evaluation samples.
  • Example 1 After the sample obtained in Example 1 was vacuum-dried at 40 ° C for 16 hours, 2 g was taken, ultrasonically washed in distilled water for 30 minutes, then immersed in 2-propanol at 60 ° Heated at C for 24 hours. Evaporate the solvent from the extract using an evaporator, and then reduce the pressure using a vacuum pump. Then, when the residual solvent was completely removed and the weight was measured, the extract was 56.9 mg. In addition, from the infrared absorption spectrum, this extract was found to be a PVP / Burmethyl imidazolium glycide copolymer. From this, it was confirmed that the polymer of Example 1 was not dispersed with a polymer compound having a monomer unit having an ammonium group in the molecule.
  • N-Buylimidazole (4.71 g, 50 mmol)
  • iodinated notachinole (12. 01 g, 50 mmol)
  • 2,6-di-tert-butyl 4-methylphenol BHT, 0.1672 g
  • the monomer (lg) represented by the formula (xl) obtained in Synthesis Example 1 above, 3,7 dimethyl-3-octanol (lg), and photoinitiator Irgacure 1850 (0.02 g) were mixed and stirred.
  • This monomer mixture was degassed under an argon atmosphere and poured into a petri dish having a diameter of 5 cm in a glove box under a nitrogen atmosphere.
  • Light irradiation Toshiba FL6D fluorescent lamp, 8.4 kilolux, 15 minutes
  • dissolved in as little methanol as possible dropped into 500 mL of ethyl acetate with stirring, and allowed to stand at 5 ° C for 3 hours.
  • the monomer yarn is formed by a silicone compound represented by the formula (yl) (23 parts by weight), the following formula (y3) [0084] [Chemical Formula 13]
  • a mixture of the obtained poly (buluoctylimidazolium iodide) (3.7 parts by weight), photoinitiator Inore Gacure 1850 (1 part by weight), 3,7-dimethyl-3-octanol (14 parts by weight)
  • the sample was subjected to the same polymerization and post-treatment as in Example 1 to obtain a sample for antibacterial evaluation.
  • a sample for antibacterial evaluation was obtained by performing polymerization and post-treatment according to the method of Example 2 except that the amount of poly (buluoctylimidazolium iodide) was changed as shown in Table 1 below.
  • a film sample was obtained in the same manner as in Example 1 except that the polymer compound was not added to the monomer mixture. It was cut into 3 cm square and used as an antibacterial evaluation sample.
  • extraction was carried out by changing the solvent to methanol, ethanol, toluene, hexane, acetone, methyl ethyl ketone, ethyl acetate, butyl acetate, tetrahydrofuran, or dimethyl sulfoxide, all of which were 0.1 weight of the dry weight of the sample. % Extract was not extracted.
  • the film-like sample obtained in Comparative Example 1 was placed in a 50 mL screw tube and immersed in an aqueous solution of 1.7% PVP / polymethylvinylimidazolium chloride (95/5) at room temperature for 16 hours.
  • Example 1 and Comparative Example 2 were immersed in 300 mL of distilled water, washed with ultrasonic waves for 15 minutes, then taken out and subjected to the same antibacterial evaluation as described above.
  • the results are shown in Table 4 below, whereas the film-like sample obtained in Comparative Example 2 that was only immersed in an antibacterial polymer aqueous solution lost its antibacterial properties and showed bacterial growth.
  • the film-like sample obtained in Example 1 was shown to have sufficient antibacterial properties even after ultrasonic cleaning.
  • extraction was carried out by changing the solvent to methanol, ethanol, toluene, hexane, acetone, methyl ethyl ketone, ethyl acetate, butyl acetate, tetrahydrofuran, or dimethyl sulfoxide, all of which were 0.1 weight of the dry weight of the sample. % Extract was not extracted.

Abstract

La présente invention concerne une lentille oculaire possédant d'excellentes propriétés antibactériennes qui ne se détériorent pas même lorsque la lentille oculaire est rincée à l'eau. La lentille oculaire est caractérisée par le fait qu'elle est obtenue en dispersant un composé polymère (A) qui contient une unité monomère possédant un groupe ammonium dans une molécule, dans un hydrogel (B).
PCT/JP2007/068831 2006-09-29 2007-09-27 Lentille oculaire WO2008038721A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2006266708A JP4899757B2 (ja) 2006-09-29 2006-09-29 眼用レンズ
JP2006-266708 2006-09-29

Publications (1)

Publication Number Publication Date
WO2008038721A1 true WO2008038721A1 (fr) 2008-04-03

Family

ID=39230156

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2007/068831 WO2008038721A1 (fr) 2006-09-29 2007-09-27 Lentille oculaire

Country Status (2)

Country Link
JP (1) JP4899757B2 (fr)
WO (1) WO2008038721A1 (fr)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2010148772A (ja) * 2008-12-26 2010-07-08 Toray Ind Inc 医療用材料
JP2010148776A (ja) * 2008-12-26 2010-07-08 Toray Ind Inc 医療用材料
WO2011004808A1 (fr) * 2009-07-08 2011-01-13 株式会社メニコン Lentille ophtalmique
EP3745998A4 (fr) * 2018-01-31 2021-09-01 KeraMed, Inc. Polymère antimicrobien destiné à être utilisé dans des implants ophtalmiques
CN116768554A (zh) * 2023-05-04 2023-09-19 盐城市福奇混凝土有限公司 一种超细矿物掺合料自密实高性能混凝土及其制备方法

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009113438A1 (fr) * 2008-03-10 2009-09-17 東レ株式会社 Composition antibactérienne pour utilisation médicale et dispositif médical
JP5332569B2 (ja) * 2008-09-10 2013-11-06 東レ株式会社 医療用材料
JP5563277B2 (ja) * 2009-10-30 2014-07-30 株式会社シード 含水性眼用レンズ
WO2011108520A1 (fr) * 2010-03-02 2011-09-09 東レ株式会社 Produit pour la peau et son procédé de production
JP6036299B2 (ja) * 2011-08-17 2016-11-30 東レ株式会社 医療デバイスおよびその製造方法
TWI496838B (zh) * 2012-11-30 2015-08-21 Pegavision Corp 矽水膠組成物及以該組成物製備之矽水膠鏡片
JP5452756B1 (ja) 2013-07-02 2014-03-26 Ｈｏｙａ株式会社 親水性表面を有するシリコーン含有共重合体成形品を作製する方法及び親水性表面を有するシリコーンハイドロゲルコンタクトレンズ

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH06256421A (ja) * 1993-02-09 1994-09-13 Ciba Geigy Ag 抗菌性第４級アンモニウム基含有重合体、その組成物及び該重合体を製造するために用いられるモノマー
JPH08510340A (ja) * 1993-05-06 1996-10-29 アラーガン、インコーポレイテッド 抗微生物レンズおよびレンズ管理システム
JP2000162556A (ja) * 1998-09-21 2000-06-16 Menicon Co Ltd 眼用レンズ材料およびその製法
JP2001220394A (ja) * 2000-02-07 2001-08-14 Toray Ind Inc モノマー、ポリマーおよび眼用レンズ
JP2001527141A (ja) * 1997-12-29 2001-12-25 ボシュ・アンド・ロム・インコーポレイテッド シリコーン含有プロポリマーおよび低含水材料
WO2005005517A2 (fr) * 2003-06-30 2005-01-20 Johnson & Johnson Vision Care, Inc. Hydrogels de silicone possedant des concentrations uniformes de polysiloxanes multifonctionnels

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2774233B2 (ja) * 1992-08-26 1998-07-09 株式会社メニコン 眼用レンズ材料
CN1278863A (zh) * 1997-11-12 2001-01-03 博士伦公司 用季化羟乙基纤维素和聚合双胍对接触镜片进行消毒
US8425926B2 (en) * 2003-07-16 2013-04-23 Yongxing Qiu Antimicrobial medical devices

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH06256421A (ja) * 1993-02-09 1994-09-13 Ciba Geigy Ag 抗菌性第４級アンモニウム基含有重合体、その組成物及び該重合体を製造するために用いられるモノマー
JPH08510340A (ja) * 1993-05-06 1996-10-29 アラーガン、インコーポレイテッド 抗微生物レンズおよびレンズ管理システム
JP2001527141A (ja) * 1997-12-29 2001-12-25 ボシュ・アンド・ロム・インコーポレイテッド シリコーン含有プロポリマーおよび低含水材料
JP2000162556A (ja) * 1998-09-21 2000-06-16 Menicon Co Ltd 眼用レンズ材料およびその製法
JP2001220394A (ja) * 2000-02-07 2001-08-14 Toray Ind Inc モノマー、ポリマーおよび眼用レンズ
WO2005005517A2 (fr) * 2003-06-30 2005-01-20 Johnson & Johnson Vision Care, Inc. Hydrogels de silicone possedant des concentrations uniformes de polysiloxanes multifonctionnels

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2010148772A (ja) * 2008-12-26 2010-07-08 Toray Ind Inc 医療用材料
JP2010148776A (ja) * 2008-12-26 2010-07-08 Toray Ind Inc 医療用材料
WO2011004808A1 (fr) * 2009-07-08 2011-01-13 株式会社メニコン Lentille ophtalmique
US9017716B2 (en) 2009-07-08 2015-04-28 Menicon Co., Ltd. Ophthalmic lens
JP5766603B2 (ja) * 2009-07-08 2015-08-19 株式会社メニコン 眼用レンズ
EP3745998A4 (fr) * 2018-01-31 2021-09-01 KeraMed, Inc. Polymère antimicrobien destiné à être utilisé dans des implants ophtalmiques
EP3850018A4 (fr) * 2018-01-31 2021-11-17 Keramed, Inc. Lentilles de contact antimicrobiennes
CN116768554A (zh) * 2023-05-04 2023-09-19 盐城市福奇混凝土有限公司 一种超细矿物掺合料自密实高性能混凝土及其制备方法

Also Published As

Publication number Publication date
JP2008083649A (ja) 2008-04-10
JP4899757B2 (ja) 2012-03-21

Similar Documents

Publication Publication Date Title
JP5600863B2 (ja) シリコーンポリマー、眼用レンズおよびコンタクトレンズ
WO2008038721A1 (fr) Lentille oculaire
AU2002236279B2 (en) Monomer, polymer, and ocular lens and contact lens each obtained therefrom
JP5633147B2 (ja) 医療用抗菌性組成物および医療用具
AU2001288111B2 (en) Polymer and ocular lens comprising the same
RU2682256C2 (ru) Силиконовый акриламидный сополимер
JP2007186709A (ja) 眼用レンズ用モノマー、眼用レンズ用ポリマーおよびコンタクトレンズ
JP2001323024A (ja) モノマー、ポリマーおよびそれを用いた眼用レンズ
WO2002081532A1 (fr) Monomeres, polymeres, lentilles ophtalmiques et lentilles de contact fabriquees a l'aide de ces derniers
JP5076256B2 (ja) モノマー組成物、それを用いたポリマーおよび眼用レンズ
AU2015241171A1 (en) Silicone acrylamide copolymer
JP5332569B2 (ja) 医療用材料
JP4123648B2 (ja) ポリマーおよびそれを用いた眼用レンズ
JP2000191730A (ja) 眼用レンズ用モノマー、眼用レンズ用ポリマーおよびそれを用いたコンタクトレンズ
JP5352983B2 (ja) 眼用レンズ
JP2009204770A (ja) 眼用レンズ
JP2002128829A (ja) モノマー、ポリマーおよびそれを用いた眼用レンズ
JP4859004B2 (ja) コンタクトレンズ、眼内レンズまたは人工角膜用のポリマーおよびコンタクトレンズ
JP2010032992A (ja) 眼用レンズ
JP4058977B2 (ja) ポリマー、それを用いた眼用レンズおよびコンタクトレンズ
JP5900424B2 (ja) 眼用レンズ
JP2001323026A (ja) モノマー、ポリマーおよび眼用レンズ
JP2001323025A (ja) モノマー、ポリマーおよびそれを用いた眼用レンズ
JP2002371116A (ja) モノマー、ポリマー、それを用いた眼用レンズおよびコンタクトレンズ

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 07828577

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 07828577

Country of ref document: EP

Kind code of ref document: A1